Hui Jiang
机构:Qingdao University, Qiqihar University, Tongji University, Ministry of Education of the People's Republic of China, Second Military Medical University, Capital Medical University, Peking University, Huazhong Agricultural University, Sichuan University, Korea University Medical Center, National Critical Care and Trauma Response Centre, Tissue Regeneration Systems (United States), West China Hospital of Sichuan University, 302 Military Hospital of China, Changhai Hospital, Shandong Provincial Hospital, Affiliated Hospital of Qingdao University, Orthopaedic Trauma Association, Peking University People's Hospital, Shanghai East Hospital, Peking University First Hospital, Regenerative Medicine Institute, Taiwan Centers for Disease Control, Peking University Third Hospital, National Institute for Communicable Disease Control and Prevention, Huazhong University of Science and Technology Hospital, Hubei Cancer Hospital, Qingdao Eighth People's Hospital, Shandong First Medical University, Beijing Obstetrics and Gynecology Hospital, Huazhong University of Science and Technology · ORCID:0000-0002-1156-9046
发表论文 122 篇 · 总被引 1026 次 · h-index 17
代表论文
- Global trends and future projections of cervical cancer burden: an integrated analysis of GBD 2021, UN population and WHO HPV vaccination data (2026 · Frontiers in Public Health · 被引 7)
- Genome wide association analysis and association of genetic risk and lifestyle with upper gastrointestinal cancer among an endoscopy-screened cohort in China (2026 · 中国科学通报:英文版 · 被引 3)
- Targeting the gut-kidney axis to improve kidney transplantation prognosis: from mechanisms to clinical intervention strategies (2026 · Renal Failure · 被引 3)
- The whole-course of supervised home-based multi-modal prehabilitation to improve clinical outcome in patients undergoing neoadjuvant chemotherapy prior to gastrectomy: a single-center randomized controlled trial (2026 · Gastric Cancer · 被引 2)
- ACT001 synergizes with temozolomide-based chemoradiotherapy to cure refractory glioblastoma by targeting TNF-CXCL10-CD8+ T-cell immunity (2026 · Frontiers in Pharmacology · 被引 2)
- Performance of latest AI models, RAG, and MCP on lung cancer-related questions (2026 · Digital Health · 被引 2)